glp-1-based treatments approved for weight loss 2025 GLP-1 Targeted Peptide Drugs Market Size to Reach USD 193.44 Billion by 2034 Market Overview: GLP-1 Agonists and

special thanks to Nan Sheng and Dewayne Falkner for flow cytometry expertise

Genetic silencing of CPT1A or -hydroxybutyrate administration inhibited the PI3K/AKT pathway, restored intestinal barrier function, attenuated inflammation, and significantly suppressed CRC advancement

Sometimes it happens, so many endless and painful diets are left behind, and the arrow of the scales stubbornly keeps at the same level

L-carnitine has broad development prospects in the field of aquatic feed additives

Network-based approaches, including WGCNA and Bayesian inference, together with machine learning, facilitate the identification of key regulatory modules and causal relationships underlying stress resilience

If you are on a higher dose of metformin, divide it up and take a smaller amount with multiple meals instead of all at once